Myocardial infarction, commonly known as a heart attack, occurs when blood flow to part of the heart is blocked. Without enough oxygen, heart muscle cells can become damaged, which may affect heart function over time.
Although modern treatments have greatly improved survival and recovery after heart attacks, researchers continue to explore regenerative approaches that may help support heart tissue repair, reduce inflammation, and improve recovery after injury. One area of growing interest is the use of exosomes derived from human umbilical cord mesenchymal stem cells, also known as HUCMSC-derived exosomes.
In this review published in Frontiers in Pharmacology, researchers examined how HUCMSC-derived exosomes may support cardiac repair after myocardial infarction. The article focused on their biological properties, therapeutic mechanisms, and potential future role in regenerative cardiovascular medicine.
What Are HUCMSC-Derived Exosomes?
Human umbilical cord mesenchymal stem cells are stem cells found in umbilical cord tissue. These cells are widely studied in regenerative medicine because they release biological signals that may influence inflammation, tissue repair, and cell survival.
Exosomes are tiny particles released by cells that act like messengers. They carry important materials from one cell to another, including:
- Proteins
- Lipids
- MicroRNAs
- Messenger RNA
- Long non-coding RNA
- Circular RNA
- Repair-related signaling molecules
Researchers are especially interested in HUCMSC-derived exosomes because they may carry many of the helpful signals associated with mesenchymal stem cells in a cell-free form.
Why Exosomes Are Being Studied for Heart Repair
After a myocardial infarction, the heart goes through several stages of injury and repair. Inflammation increases, heart muscle cells may become stressed, scar tissue can form, and blood vessel growth may be limited. If this process is not well controlled, the heart may remodel in ways that affect long-term function.
According to the review, HUCMSC-derived exosomes may support heart repair by influencing several important processes at once, including:
- Reducing excessive inflammation
- Supporting heart cell survival
- Encouraging new blood vessel formation
- Reducing oxidative stress
- Limiting excessive fibrosis
- Improving communication between damaged and healthy cells
- Supporting cardiac repair pathways
This broad range of activity is one reason exosomes are receiving attention in cardiovascular regenerative medicine research.
Key Therapeutic Mechanisms
One major benefit of HUCMSC-derived exosomes is that they may work through multiple connected mechanisms rather than one single pathway.
After a heart attack, some heart muscle cells experience severe stress due to low oxygen, inflammation, and oxidative damage. HUCMSC-derived exosomes may help reduce cell death by delivering protective signals that support cell survival pathways.
They may also promote angiogenesis, which is the formation of new blood vessels. This is important because damaged heart tissue needs oxygen and nutrients to heal properly. By encouraging endothelial cells to grow, move, and form vessel-like structures, these exosomes may help improve the repair environment.
The review also highlights their role in regulating inflammation. Inflammation is part of the healing process, but too much inflammation can contribute to additional tissue stress. HUCMSC-derived exosomes may help shift the immune response toward a more repair-supportive state.
In addition, these exosomes may help reduce oxidative stress and limit excessive fibrosis. Oxidative stress can damage heart cells, while too much fibrosis can make heart tissue less flexible. By influencing these pathways, HUCMSC-derived exosomes may support healthier cardiac remodeling after injury.
The Role of microRNAs and Molecular Cargo
A key part of exosome research is understanding what these vesicles carry. HUCMSC-derived exosomes contain molecular cargo that may influence cardiac repair, including microRNAs, long non-coding RNAs, circular RNAs, and bioactive proteins.
The review discussed several microRNAs that may play a role in heart protection and regeneration, including:
- miR-29b
- miR-133a-3p
- miR-24-3p
- miR-100-5p
- miR-204
- miR-1246
MicroRNAs help regulate gene activity and can influence inflammation, fibrosis, angiogenesis, cell survival, and tissue repair. Because exosomes can deliver these microRNAs to target cells, they may help coordinate multiple parts of the healing process at the same time.
Engineered Exosomes and Future Possibilities
The review also explored engineered exosomes, which are exosomes modified to improve their targeting, stability, delivery, or therapeutic activity. Researchers are studying strategies such as:
- Genetic modification
- Surface engineering
- Biomaterial-based delivery systems
- Hydrogel or patch-based delivery
- Targeted exosome loading
- Sustained-release systems
These approaches may help exosomes remain active longer, reach damaged heart tissue more effectively, and deliver specific repair signals with greater precision.
Why This Research Matters
Heart attacks can have long-term effects on heart structure and function. Even with current medical treatments, researchers continue to look for ways to support repair after the initial injury.
This review highlights HUCMSC-derived exosomes as a promising area of regenerative medicine research because they may support several repair processes at once. Instead of targeting only one pathway, these exosomes may help regulate inflammation, promote blood vessel growth, reduce cell stress, and support healthier cardiac remodeling.
The article also shows how regenerative medicine is moving beyond whole-cell therapies. Exosome-based approaches may offer many of the signaling benefits associated with mesenchymal stem cells while allowing researchers to refine delivery, dosing, and therapeutic targeting.
A Promising Direction for Cardiac Regenerative Medicine
Human umbilical cord MSC-derived exosomes represent an exciting area of research for myocardial infarction and heart repair. Their ability to carry repair signals, regulate inflammation, promote angiogenesis, reduce oxidative stress, and support cardiac remodeling makes them a strong focus for future regenerative medicine studies.
While more research is still needed before these approaches become widely used in clinical care, this review highlights the growing potential of HUCMSC-derived exosomes as a cell-free regenerative strategy for supporting heart repair after myocardial infarction.
Source
Ding N, Zheng Z, Zhang C. Therapeutic potential of human umbilical cord mesenchymal stem cell-derived exosomes in myocardial infarction: from molecular mechanisms to clinical translation-an update. Front Pharmacol. 2025 Sep 10;16:1667140. doi: 10.3389/fphar.2025.1667140. Available from: https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2025.1667140/full
Related Treatment Pages